Companies › CVS Health · Global Markets & Policy
CVS Health Corporation
- NYSE: CVS
US pharmacy chain, pharmacy benefit manager (Caremark) and health insurer (Aetna).
Next earnings report: Nov 4, 2026. CVS Health quarterly results and earnings history →
Insider trades (Form 4)
Last 120 days: open-market sales $0, purchases $0. All CVS Health insider transactions →
Key financials
| Metric | FY to Dec 2022 | FY to Dec 2023 | FY to Dec 2024 | FY to Dec 2025 |
|---|---|---|---|---|
| Revenue | $322.5B | $357.8B | $372.8B | $402.1B |
| Operating income | $8.0B | $13.7B | $8.5B | $4.7B |
| Net income | $4.3B | $8.3B | $4.6B | $1.8B |
| Diluted EPS | $3.26 | $6.47 | $3.66 | $1.39 |
Fiscal years, from annual reports (10-K / 20-F). Source: SEC EDGAR (XBRL company facts), retrieved 2026-10-14. Verify figures against the original filings.
Recent filings
- 2026-08-17 · 8-K — Director or officer change; Regulation FD disclosure
- 2026-08-05 · 10-Q
- 2026-08-05 · 8-K — Results of operations
- 2026-05-18 · 8-K — Director or officer change; Shareholder vote results
- 2026-05-06 · 10-Q
- 2026-05-06 · 8-K — Results of operations
- 2026-04-03 · DEF 14A
- 2026-03-19 · 8-K — Director or officer change
Source: SEC EDGAR, retrieved 2026-10-14. Filing types explained: 8-K, 10-Q, 10-K, 20-F / 6-K.
Not investment advice. This page lists official filings and our reports for reference. SignalStack does not rate securities or recommend buying or selling anything.